Midcap Value Alert: 3 Years of Subscription at the Price of 1
Here is the latest financial fact sheet of DR. REDDYS LAB. For more details, see the DR. REDDYS LAB quarterly results and DR. REDDYS LAB share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.3 |
No. of shares | m | 166.82 |
1 Week | % | -6.2 |
1 Month | % | -4.4 |
1 Year | % | 19.6 |
52 week H/L | Rs | 6,505.5/4,383.4 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
DR. REDDYS LAB EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 2,875 | 3,363 | 5,515 | 5,614 | 4,656 | |
Low | Rs | 1,888 | 2,352 | 3,028 | 3,655 | 3,788 | |
Sales per share (Unadj.) | Rs | 930.2 | 1,054.2 | 1,145.4 | 1,293.8 | 1,481.4 | |
Earnings per share (Unadj.) | Rs | 117.4 | 121.9 | 117.4 | 131.1 | 270.7 | |
Diluted earnings per share | Rs | 116.9 | 121.4 | 117.0 | 130.8 | 270.2 | |
Cash flow per share (Unadj.) | Rs | 185.8 | 191.9 | 191.2 | 201.0 | 345.7 | |
Dividends per share (Unadj.) | Rs | 20.00 | 25.00 | 25.00 | 30.00 | 40.00 | |
Adj. dividends per share | Rs | 19.91 | 24.90 | 24.92 | 29.95 | 39.93 | |
Avg Dividend yield | % | 0.8 | 0.9 | 0.6 | 0.6 | 0.9 | |
Book value per share (Unadj.) | Rs | 839.7 | 932.5 | 1,053.2 | 1,145.1 | 1,389.6 | |
Adj. book value per share | Rs | 835.9 | 928.9 | 1,050.0 | 1,143.1 | 1,387.2 | |
Shares outstanding (eoy) | m | 166.07 | 166.17 | 166.30 | 166.53 | 166.53 | |
Price / Sales ratio | x | 2.6 | 2.7 | 3.7 | 3.6 | 2.8 | |
Avg P/E ratio | x | 20.3 | 23.4 | 36.4 | 35.4 | 15.6 | |
P/CF ratio (eoy) | x | 12.8 | 14.9 | 22.3 | 23.1 | 12.2 | |
Price / Book Value ratio | x | 2.8 | 3.1 | 4.1 | 4.0 | 3.0 | |
Dividend payout | % | 17.0 | 20.5 | 21.3 | 22.9 | 14.8 | |
Avg Mkt Cap | Rs m | 395,486 | 474,837 | 710,290 | 771,744 | 703,039 | |
Total wages/salary | Rs m | 33,562 | 33,802 | 36,299 | 38,858 | 46,466 |
DR. REDDYS LAB INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 154,482 | 175,170 | 190,475 | 215,452 | 246,697 | |
Other income | Rs m | 3,375 | 6,206 | 2,914 | 4,847 | 10,555 | |
Total revenues | Rs m | 157,857 | 181,376 | 193,389 | 220,299 | 257,252 | |
Gross profit | Rs m | 32,220 | 25,265 | 39,179 | 38,377 | 63,860 | |
Depreciation | Rs m | 11,348 | 11,631 | 12,288 | 11,652 | 12,502 | |
Interest | Rs m | 889 | 983 | 970 | 958 | 1,428 | |
Profit before tax | Rs m | 23,358 | 18,857 | 28,835 | 30,614 | 60,485 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 3,858 | -1,403 | 9,319 | 8,789 | 15,412 | |
Profit after tax | Rs m | 19,500 | 20,260 | 19,516 | 21,825 | 45,073 | |
Gross profit margin | % | 20.9 | 14.4 | 20.6 | 17.8 | 25.9 | |
Effective tax rate | % | 16.5 | -7.4 | 32.3 | 28.7 | 25.5 | |
Net profit margin | % | 12.6 | 11.6 | 10.2 | 10.1 | 18.3 |
DR. REDDYS LAB BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 111,101 | 125,991 | 145,352 | 177,879 | 203,161 | |
Current liabilities | Rs m | 58,973 | 72,141 | 81,038 | 97,658 | 85,721 | |
Net working cap to sales | % | 33.7 | 30.7 | 33.8 | 37.2 | 47.6 | |
Current ratio | x | 1.9 | 1.7 | 1.8 | 1.8 | 2.4 | |
Inventory Days | Days | 72 | 71 | 50 | 56 | 79 | |
Debtors Days | Days | 94 | 105 | 95 | 113 | 107 | |
Net fixed assets | Rs m | 109,238 | 94,063 | 109,979 | 106,820 | 112,638 | |
Share capital | Rs m | 830 | 831 | 832 | 832 | 833 | |
"Free" reserves | Rs m | 138,611 | 154,119 | 174,319 | 189,859 | 230,571 | |
Net worth | Rs m | 139,441 | 154,950 | 175,151 | 190,691 | 231,404 | |
Long term debt | Rs m | 22,000 | 1,304 | 6,299 | 5,746 | 1,278 | |
Total assets | Rs m | 220,339 | 220,054 | 255,482 | 284,699 | 315,799 | |
Interest coverage | x | 27.3 | 20.2 | 30.7 | 33.0 | 43.4 | |
Debt to equity ratio | x | 0.2 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 | |
Return on assets | % | 9.3 | 9.7 | 8.0 | 8.0 | 14.7 | |
Return on equity | % | 14.0 | 13.1 | 11.1 | 11.4 | 19.5 | |
Return on capital | % | 15.0 | 12.7 | 16.4 | 16.1 | 26.6 | |
Exports to sales | % | 57.4 | 48.1 | 51.3 | 47.1 | 52.2 | |
Imports to sales | % | 12.4 | 22.6 | 18.1 | 18.8 | 16.8 | |
Exports (fob) | Rs m | 88,673 | 84,193 | 97,699 | 101,544 | 128,803 | |
Imports (cif) | Rs m | 19,104 | 39,616 | 34,420 | 40,401 | 41,484 | |
Fx inflow | Rs m | 88,673 | 84,193 | 97,699 | 101,544 | 128,803 | |
Fx outflow | Rs m | 19,104 | 39,616 | 34,420 | 40,401 | 41,484 | |
Net fx | Rs m | 69,569 | 44,577 | 63,279 | 61,143 | 87,319 |
DR. REDDYS LAB CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 28,704 | 29,841 | 35,703 | 28,108 | 58,875 | |
From Investments | Rs m | -7,727 | -4,923 | -22,660 | -26,387 | -41,373 | |
From Financial Activity | Rs m | -21,326 | -25,159 | -298 | -2,422 | -26,861 | |
Net Cashflow | Rs m | -314 | -266 | 12,858 | 32 | -9,073 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: K Satish Reddy | COMP SEC: K Randhir Singh | YEAR OF INC: 1984 | BSE CODE: 500124 | FV (Rs): 5 | DIV YIELD (%): 0.7 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES ZYDUS LIFESCIENCES CIPLA SUN PHARMA MANKIND PHARMA
Compare DR. REDDYS LAB With: DIVIS LABORATORIES ZYDUS LIFESCIENCES CIPLA SUN PHARMA MANKIND PHARMA
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.